Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Cell Physiol Biochem ; 51(6): 2523-2535, 2018.
Article in English | MEDLINE | ID: mdl-30562752

ABSTRACT

BACKGROUND/AIMS: Inflammation plays a vital role in the etiology and pathogenesis of chronic noncommunicable diseases (NCDs), which are the leading health issues throughout the world. Our previous studies verified the satisfactory therapeutic effects of Coccomyxa gloeobotrydiformis (CGD) polysaccharide on several NCDs. In this study, we aimed to investigate the anti-inflammatory effects of CGD polysaccharide, and the corresponding molecular mechanisms, on lipopolysaccharide (LPS)-induced inflammation in RAW264.7 cells. METHODS: A viability assay and a lactate dehydrogenase (LDH) assay were used to measure the cytotoxic effects of CGD polysaccharide on LPS-stimulated RAW264.7 cells. To investigate the potential anti-inflammatory mechanisms of CGD polysaccharide in LPS-stimulated RAW264.7 cells, nitric oxide (NO) production was determined using a NO assay and the expression of inflammatory mediators (PGE2, iNOS and COX-2), inflammatory cytokines (TNF-α, IL-6, IL-1ß and IL-10) and inflammation-related signaling pathways (the MAPK/NF-κB, PI3K/AKT/JNK, JAK/STAT and Nrf2/HO-1pathways) were observed by western blotting. The translocation of NF-κB p65 was also observed using an immunofluorescent assay. RESULTS: CGD polysaccharide significantly inhibited LPS-induced NO production and PGE2 expression by reducing the expression of iNOS and COX-2. It also suppressed the expression of the pro-inflammatory cytokines TNF-α, IL-6 and IL-1ß, and up-regulated the expression of the anti-inflammatory cytokine IL-10. Further experiments demonstrated that CGD polysaccharide could inhibit inflammatory signaling pathways (the MAPK/NF-κB, PI3K/AKT/JNK and JAK/STAT pathways). At the same time, it enhanced the anti-inflammatory pathway Nrf2/HO-1. In addition, CGD polysaccharide did not display any cytotoxic effects, even at a high concentration. CONCLUSION: Taken together, the results suggest that CGD polysaccharide significantly inhibits LPS-induced inflammation in RAW264.7 cells. This effect lies in its regulatory effects on the signaling pathways MAPK/ NF-κB, PI3K/AKT/JNK, JAK/STAT and Nrf2/HO-1.Our findings reveal that CGD polysaccharide has the potential to be used as a relatively safe and effective drug as part of the treatment of NCDs.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Inflammation/drug therapy , Lipopolysaccharides/immunology , Macrophages/drug effects , Polysaccharides/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Cyclooxygenase 2/immunology , Cytokines/immunology , Dinoprostone/immunology , Inflammation/immunology , Macrophages/immunology , Mice , Microalgae/chemistry , Nitric Oxide/immunology , Nitric Oxide Synthase Type II/immunology , Polysaccharides/chemistry , RAW 264.7 Cells
2.
Infect Immun ; 85(10)2017 10.
Article in English | MEDLINE | ID: mdl-28760936

ABSTRACT

Activation of caspase-11 by some Gram-negative bacteria triggers the caspase-1/interleukin 1ß (IL-1ß) pathway, independent of canonical inflammasomes. Acinetobacter baumannii is a Gram-negative, conditionally pathogenic bacterium that can cause severe pulmonary infection in hospitalized patients. A. baumannii was revealed to activate canonical and noncanonical inflammasome pathways in bone marrow-derived macrophages (BMDMs). Pulmonary infection of caspase-11-/- mice with A. baumannii showed that caspase-11 deficiency impaired A. baumannii clearance, exacerbated pulmonary pathological changes, and enhanced susceptibility to A. baumannii These data indicate that the caspase-11-mediated innate immune response plays a crucial role in defending against A. baumannii.


Subject(s)
Acinetobacter Infections/immunology , Acinetobacter baumannii/immunology , Caspases/metabolism , Immunity, Innate , Macrophages/immunology , Respiratory Tract Infections/immunology , Acinetobacter Infections/enzymology , Acinetobacter Infections/prevention & control , Acinetobacter baumannii/metabolism , Acinetobacter baumannii/pathogenicity , Animals , Caspases/deficiency , Caspases/genetics , Caspases, Initiator , Inflammasomes/immunology , Interleukin-1beta/immunology , Lung/immunology , Lung/microbiology , Lung/pathology , Macrophages/microbiology , Mice , Mice, Knockout , Respiratory Tract Infections/enzymology , Respiratory Tract Infections/pathology
3.
Cell Physiol Biochem ; 43(3): 959-968, 2017.
Article in English | MEDLINE | ID: mdl-28957804

ABSTRACT

BACKGROUND/AIMS: The direct consequence of metabolic syndrome (MS) is the increased morbidity and mortality caused by the heart disease. We tried to explain why the heart is more severely damaged during MS from the point of mitochondria, the center of cellular metabolism. METHODS: 1. The classic diet induced MS rat model was used to observe the morphological changes of mitochondria by transmission electron microscope (TEM); 2. The expression of mitochondrial DNA (mt-DNA) encoded proteins was observed by immunohistochemistry and Western blot; 3. The expression of mitochondrial ribosomal proteins (MRPs) was observed by real-time PCR. RESULTS: 1. The mitochondrial volume increased but the number was normal in myocardial cells of the MS rats. But in the hepatocytes and skeletal muscle cells, the mitochondrial number decreased; 2.The mt-DNA encoded protein cytochrome b increased significantly in heart but decreased in liver and the ATPase6 increased in liver but decreased in heart of the MS rats; 3. The mRNA levels of MRPS23, MRPL27, MRPL45 and MRPL48 elevated in heart but down-regulated in liver of the MS rats. CONCLUSION: The morphologic and functional alterations of mitochondrion in MS were tissue specific. Heart displays a distinctive pattern of mitochondrial metabolic status compared with other tissues.


Subject(s)
DNA, Mitochondrial/metabolism , Heart Diseases/etiology , Metabolic Syndrome/pathology , Mitochondria/genetics , Mitochondrial Proteins/metabolism , Animals , Cytochromes b/metabolism , Disease Models, Animal , Heart Diseases/metabolism , Immunohistochemistry , Liver/metabolism , Male , Metabolic Syndrome/metabolism , Microscopy, Electron, Transmission , Mitochondria/metabolism , Mitochondria/pathology , Mitochondrial Proteins/genetics , Mitochondrial Proton-Translocating ATPases/metabolism , Muscle, Skeletal/metabolism , Myocardium/metabolism , Rats , Rats, Sprague-Dawley , Ribosomal Proteins/genetics , Ribosomal Proteins/metabolism
4.
Biotechnol Lett ; 38(6): 931-9, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26932904

ABSTRACT

OBJECTIVES: To explore the effect of placenta-derived mesenchymal stem cells on scar formation as well as the underlying mechanism. RESULTS: The isolated placenta-derived mesenchymal stem cells from mice were distributed in the wounded areas of scalded mouse models, attenuated inflammatory responses and decreased the deposition of collagens, thus performing a beneficial effect against scar formation. Hypoxia enhanced the protective effect of placenta-derived mesenchymal stem cells and hypoxia-inducible factor-1α was involved in the protective effect of placenta-derived mesenchymal stem cells in hypoxic condition. CONCLUSIONS: Hypoxia enhanced the protective effect of placenta-derived mesenchymal stem cells through hypoxia-inducible factor-1α and PMSCs may have a potential application in the treatment of wound.


Subject(s)
Cicatrix/prevention & control , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Mesenchymal Stem Cell Transplantation/methods , Placenta/cytology , Animals , Cell Hypoxia , Cicatrix/metabolism , Cicatrix/pathology , Collagen/metabolism , Culture Media, Conditioned/chemistry , Culture Media, Conditioned/pharmacology , Female , Inflammation/prevention & control , Inflammation/therapy , Mesenchymal Stem Cells/physiology , Mice, Inbred C57BL , Pregnancy , Wound Healing/physiology
5.
BMC Cancer ; 14: 480, 2014 Jul 03.
Article in English | MEDLINE | ID: mdl-24993819

ABSTRACT

BACKGROUND: Both Wnt5a overexpression and macrophage infiltration have been implicated in inflammation and cancer. The aim of this study is to reveal the involvement of Wnt5a in macrophage recruitment in gastric cancer. METHODS: mRNA expression in gastric cancer tissues and cells was investigated by real-time PCR. Protein secretion by gastric cancer cells was determined by ELISA. PcDNA3.1-Wnt5a expression vector and Wnt5a siRNA vector were used to overexpress and silence Wnt5a expression in gastric cells, respectively. Macrophage migration was analyzed by transwell, and macrophage cytoskeleton was stained with FITC-phalloidin. RESULTS: Wnt5a was overexpressed in gastric cancer tissues, and correlated with monocyte chemotactic protein 1 (MCP-1) and interleukin 1ß (IL-1ß), respectively. In gastric cancer cells, Wnt5a induced MCP-1 expression, which was mediated by IL-1ß. Conditioned medium from gastric cancer cells transfected with Wnt5a stimulated macrophage chemotaxis and cytoskeletal changes via MCP-1, which were suppressed by recombinant IL-1 receptor antagonist (rIL-1Ra). CONCLUSIONS: These results suggest that Wnt5a is involved in macrophage recruitment by upregulating MCP-1, and IL-1Ra may be used to inhibit macrophage recruitment in gastric cancer.


Subject(s)
Chemokine CCL2/genetics , Interleukin-1beta/metabolism , Proto-Oncogene Proteins/metabolism , Stomach Neoplasms/genetics , Stomach Neoplasms/metabolism , Wnt Proteins/metabolism , Animals , Cell Line , Cell Line, Tumor , Chemokine CCL2/metabolism , Chemotaxis, Leukocyte , Cytoskeleton/metabolism , Gene Expression , Gene Expression Regulation, Neoplastic , Humans , Macrophages/immunology , Macrophages/metabolism , Mice , Proto-Oncogene Proteins/genetics , RNA, Messenger/genetics , Stomach Neoplasms/immunology , Up-Regulation , Wnt Proteins/genetics , Wnt-5a Protein
6.
Life Sci ; 149: 51-7, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26892145

ABSTRACT

AIMS: Scar formation after wound repair affects people's daily life. Mesenchymal stem cells were reported to have a beneficial role in attenuating the scar formation. In the present study, placenta-derived mesenchymal stem cells (PMSCs) were isolated and the effects of hypoxic conditioned medium of PMSCs on scar formation were explored. MAIN METHODS: To evaluate the effect of hypoxia on PMSCs, proliferation of PMSCs was detected by trypan blue staining and the HIF-1α level was detected by western blot. Then in vivo scar formation assay was performed and the histopathologic changes were evaluated by HE staining and levels of TGF-ß1 and collagen I were detected by quantitative real-time PCR. The IL-10 level was detected by ELISA and then migration of HFF-1 cells was detected by wound healing assay after treatment with IL-10 or IL-10 antibody. KEY FINDINGS: Our study showed that hypoxic conditioned medium of PMSCs reduced scar formation in vivo and inhibited the proliferation and migration of skin fibroblasts in vitro. Further mechanism study showed that, the level of IL-10 was affected by hypoxia, treatment with IL-10 mimicked the function of hypoxic conditioned medium of PMSCs and inhibition of IL-10 reversed the protective role of hypoxic conditioned medium of PMSCs. Thus, hypoxic conditioned medium of PMSCs may perform the protective role against scar formation through IL-10. SIGNIFICANCE: Our study reveals a possible mechanism of the protective effect of PMSCs against scar formation and provides evidence for the hypothesis that PMSCs may be a promising therapy for the treatment of wounds.


Subject(s)
Cicatrix/metabolism , Cicatrix/prevention & control , Culture Media, Conditioned/pharmacology , Mesenchymal Stem Cells/physiology , Placenta/cytology , Placenta/physiology , Animals , Cell Differentiation/drug effects , Cell Differentiation/physiology , Cell Hypoxia/drug effects , Cell Hypoxia/physiology , Cells, Cultured , Female , Humans , Infant, Newborn , Mice , Mice, Inbred C57BL , Pregnancy
7.
PLoS One ; 9(1): e85058, 2014.
Article in English | MEDLINE | ID: mdl-24416340

ABSTRACT

Aberrant macrophage infiltration and activation has been implicated in gastric inflammation and carcinogenesis. Overexpression of Wnt5a and downregulation of SFRP5, a Wnt5a antagonist, were both observed in gastric cancers recently. This study attempted to explore whether Wnt5a/SFRP5 axis was involved in macrophage chemotaxis and activation. It was found that both Wnt5a transfection and recombinant Wnt5a (rWnt5a) treatment upregulated CCL2 expression in macrophages, involving JNK and NFκB signals. Conditioned medium from Wnt5a-treated macrophages promoted macrophage chemotaxis mainly dependent on CCL2. SFRP5 from gastric epithelial cells (GECs) inhibited Wnt5a-induced CCL2 expression and macrophage chemotaxis. In addition, Wnt5a treatment stimulated macrophages to produce inflammatory cytokines and COX-2/PGE2, which was also suppressed by SFRP5 from GECs. These results demonstrate that Wnt5a induces macrophage chemotaxis and activation, which can be blocked by GEC-derived SFRP5, suggesting that Wnt5a overproduction and SFRP5 deficiency in gastric mucosa may together play an important role in gastric inflammation and carcinogenesis.


Subject(s)
Cell Transformation, Neoplastic/genetics , Chemotaxis/drug effects , Epithelial Cells/metabolism , Eye Proteins/pharmacology , Gene Expression Regulation, Neoplastic , Macrophage Activation/drug effects , Membrane Proteins/pharmacology , Adaptor Proteins, Signal Transducing , Cell Line , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Chemotaxis/genetics , Culture Media, Conditioned/pharmacology , Cyclooxygenase 2/genetics , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , Epithelial Cells/pathology , Eye Proteins/genetics , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Humans , MAP Kinase Kinase 4/genetics , MAP Kinase Kinase 4/metabolism , Macrophages/drug effects , Macrophages/metabolism , Macrophages/pathology , Membrane Proteins/deficiency , Membrane Proteins/genetics , NF-kappa B/genetics , NF-kappa B/metabolism , Primary Cell Culture , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins/pharmacology , Signal Transduction , Wnt Proteins/genetics , Wnt Proteins/metabolism , Wnt Proteins/pharmacology , Wnt-5a Protein
SELECTION OF CITATIONS
SEARCH DETAIL